Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to PTCT Full portfolio

Position in PTCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$26,243,607
-$61,448,794 QoQ
Shares Held
385,199
-66.6% QoQ
Ownership
0.464%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Derivatives in PTCT

reported options exposure · as of Mar 31, 2026
CallValue
$1,185,462
CallShares
17,400
PutValue
$742,617
PutShares
10,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. PTCT ranks #46 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in PTCT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,185,462 17,400
2026-03-31 $26,243,607 385,199
2026-03-31 $742,617 10,900
2025-12-31 $888,732 11,700
2025-12-31 $87,692,401 1,154,455
2025-12-31 $577,296 7,600
2025-09-30 $1,472,880 24,000
2025-09-30 $521,645 8,500
2025-09-30 $106,233,003 1,731,025
2025-06-30 $590,964 12,100
2025-06-30 $1,699,632 34,800
2025-06-30 $44,956,878 920,493
2025-03-31 $626,808 12,300
2025-03-31 $438,256 8,600
2025-03-31 $59,501,966 1,167,621
2024-12-31 $762,866 16,900
2024-12-31 $20,674,796 458,015
2024-12-31 $234,728 5,200
2024-09-30 $8,871,685 239,129
2024-09-30 $211,470 5,700
2024-09-30 $549,080 14,800
2024-06-30 $8,259,015 270,079
2024-06-30 $143,726 4,700
2024-06-30 $262,988 8,600
2024-03-31 $2,926,454 100,600
2024-03-31 $824,352 28,338
2024-03-31 $180,358 6,200
2023-12-31 $567,736 20,600
2023-12-31 $8,017,699 290,918
2023-12-31 $223,236 8,100
2023-09-30 $156,870 7,000
2023-09-30 $2,810,348 125,406
2023-09-30 $181,521 8,100
2023-06-30 $569,380 14,000
2023-06-30 $296,891 7,300
2023-06-30 $3,022,105 74,308
2023-03-31 $1,472,576 30,400
2023-03-31 $1,259,440 26,000
2022-12-31 $95,425 2,500
2022-12-31 $53,247 1,395
2022-12-31 $1,248,159 32,700
2022-09-30 $1,425,680 28,400
2022-09-30 $5,286,060 105,300
2022-09-30 $19,225,846 382,985
2022-06-30 $757,134 18,900
2022-06-30 $5,031,536 125,600
2022-06-30 $3,044,359 75,995
2022-03-31 $3,518,593 94,307
2021-12-31 $338,555 8,500
2021-12-31 $669,183 16,801

Report a Problem

Category
Description
Email (optional, for follow-up)